Turning Point
Dana-Farber discoveries benefit women in other cities and countries. DFCI leadership pictured clockwise from top: Eric Winer, MD, and his patient Joan Morgan; Judy Garber, MD, MPH; J. Dirk Iglehart, MD.
Spring/Summer 2006
Contents
At home and in the world
By J.Dirk Iglehart, MDLeading the way
By Dawn Stapleton
How DFCI research affects women beyond our doorsBanding together
By Rob Levy
WCP leaders spur new breast cancer consortiumCancer vaccines:
By Richard Saltus
Pursuing the promise
Can immunotherapy aid the war against women's cancers?More than medicine
By Rob Levy
Care Coordination tends to patients' emotional and practical needsFinding a needle in a haystack
By Dawn Stapleton
Searching for biomarkers of ovarian cancersResearch Notes
Ask the Care Team
Credits
Turning Point is published for supporters of Dana-Farber's Women's
Cancers Program. To learn more about the WCP, call Administrative
Director Candace S. Lowe, ScD, at (617) 632-2675.
Comments, suggestions, and requests to be added to or deleted from the mailing
list may be sent to:
Turning Point
Dana-Farber Cancer Institute
Department of Communications
44 Binney Street, OS-300
Boston, MA 02115
or call (617) 632-4090
or e-mail: TurningPoint@dfci.harvard.edu
EDITOR: Dawn Stapleton
ASSOCIATE EDITOR: Richard Saltus
SCIENCE ADVISORS: Ian Krop, MD, PhD; Jennifer Ligibel, MD
ART DIRECTOR: John DiGianni
DESIGN: Kimberly Regensburg
CONTRIBUTORS: Robert Levy, Kristin Zawadzki, Irina Zlobina
PRODUCTION COORDINATOR: Kathleen Raven
PHOTOGRAPHY: Bill Horsman, Sam Ogden
